Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, xinjiang uygur autonomous region, china

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Qi, Ying Cheng ^a   Ma, Mai Juan ^b   Li, Dong Jun ^c   Chen, Mei Juan ^a   Lu, Qing Bin ^b,d   Li, Xiu Jun ^b,d   Li, Jun Lian ^a   Liu, Wei ^b   Cao, Wu Chun ^b  

^a Department of Pediatrics Chest Hospital of Xinjiang Uygur Autonomous Region   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c Emergency Center of Red Cross Aid Center of Urumqi   (China)

^d SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; PROTIONAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATION; CHILD; CHINA; ETHNIC DIFFERENCE; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEMALE; HUMAN; IN VITRO STUDY; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRESCHOOL CHILD; PREVALENCE; PROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT PLANNING; ASIAN; ETHNIC GROUP; ETHNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; SPUTUM;

MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNIC GROUPS; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84863144900     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032103     Document Type: Article

References (25)

1. WHO (2007b) Global Tuberculosis Control: Surveillance, Planning, Financing, WHO report 2007, WHO/HTM/TB/2007.376 Geneva World Health Organization.
2. WHO (2011) Global Ttuberculosis Control 2010 Geneva, Switzerland World Health Organization.
3. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, et al. (2010) Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375: 1830-1843.
4. WHO (2004) Bulletin of world health organization. WHO News 82: 716.
5. Raviglione M, (2006) XDR-TB: entering the post-antibiotic era? Int J Tuberc Lung Dis 10: 1185-1187.
6. Health CMo (2010) National Baseline Survey of Drug-resistant Tuberculosis (2007-2008). People's Medical Publishing House.
7. Bureau of Health XUAR (2011) World TB Day. Bulletin.
8. Jin X, Fan X, (2002) Study on prevalence trends and control measures of tuberculosis in Xinjiang Uygur Autonomous Region. Xinjiang medcine journal (Chinese) 32: 25-27.
9. Pillay M, Sturm AW, (2007) Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clin Infect Dis 45: 1409-1414.
10. WHO (2008) Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 2002-2007 Geneva, Switzerland World Health Organization.
11. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, et al. (2009) Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373: 1861-1873.
12. Deng Y, Wang Y, Wang J, Jing H, Yu C, et al. (2011) Laboratory-based surveillance of extensively drug-resistant tuberculosis, China. Emerg Infect Dis 17: 495-497.
13. Tang S, Zhang Q, Yu J, Liu Y, Sha W, et al. (2011) Extensively drug-resistant tuberculosis, China. Emerg Infect Dis 17: 558-560.
14. Sun Z, Chao Y, Zhang X, Zhang J, Li Y, et al. (2008) Characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates in China. J Clin Microbiol 46: 4075-4077.
15. Zhao M, Li X, Xu P, Shen X, Gui X, et al. (2009) Transmission of MDR and XDR tuberculosis in Shanghai, China. PLoS One 4: e4370.
16. Tang S, Zhang Q, Yu J, Liu Y, Sha W, et al. (2011) Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes. Scand J Infect Dis 43: 280-285.
17. Murase Y, Maeda S, Yamada H, Ohkado A, Chikamatsu K, et al. (2010) Clonal expansion of multidrug-resistant and extensively drug-resistant tuberculosis, Japan. Emerg Infect Dis 16: 948-954.
18. Yang Y, Li X, Zhou F, Jin Q, Gao L, (2011) Prevalence of drug-resistant tuberculosis in mainland china: systematic review and meta-analysis. PLoS One 6: e20343.
19. Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, et al. (2008) Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa. Int J Tuberc Lung Dis 12: 99-104.
20. Blower S, Supervie V, (2007) Predicting the future of XDR tuberculosis. Lancet Infect Dis 7: 443.
21. WHO (2003) Treatment of tuberculosis: guidelines for national programmes Geneva, Switzerland World Health Organization.
22. WHO (2006) World health report 2006: working together for health Geneva, Switzerland World Health Organization.
23. Lonnroth K, Lambregts K, Nhien DT, Quy HT, Diwan VK, (2000) Private pharmacies and tuberculosis control: a survey of case detection skills and reported anti-tuberculosis drug dispensing in private pharmacies in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 4: 1052-1059.
24. WHOStopTBPartnership (2006) The global plan to stop TB, 2006-2015. Report No: WHO/HTM/STB.2006.35.
25. Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, et al. (2008) Extensively drug-resistant tuberculosis in california, 1993-2006. Clin Infect Dis 47: 450-457.